Fabrinet vs QXO Inc. Common Stock — how do they compare? Fabrinet trades at $384 (market cap $15.33B), while QXO Inc. Common Stock trades at $10.37 (market cap $11.43B). The key difference: Fabrinet is the larger of the two by market cap, and QXO Inc. Common Stock is more actively traded (21,645,941 versus 1,120,187). Which is the better fit depends on your goals — on Pluang, investors hold Fabrinet for 31 Days and QXO Inc. Common Stock for 0 Days on average.
| FN | QXO | |
|---|---|---|
Market Cap | $15.33B | $11.43B |
Volume | 1,120,187 | 21,645,941 |
Sector | Technology | Industrials |
52-Week High | $746.47 | $27.07 |
52-Week Low | $374.91 | $10.33 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $14.46B | $16.75B |
Signals from Pluang's Aura AI — not financial advice
Fabrinet (FN) trades at $427.82, down 6.26% in the last session amid broader market volatility. The stock shows strong fundamental performance with three consecutive quarterly earnings beats and robust 45% revenue growth in Q4 2026. Technical indicators present a mixed picture with a bullish overall signal but bearish moving averages, while support levels cluster around $407-$441. The company benefits from surging AI data center demand and capacity expansion initiatives.
Fabrinet's outlook remains positive driven by AI infrastructure growth, though risks include customer concentration and margin pressure. Analysts project 64% upside to the $769.50 consensus target with unanimous bullish sentiment (18 buys, 0 sells). The stock offers exposure to high-growth optical manufacturing but faces execution risks in capital expansion.
QXO trades at $11.02, up 3.57% on the day but down significantly year-to-date amid weak residential demand and integration challenges from its TopBuild acquisition. The stock shows neutral technical signals with support near $10-$11 and resistance at $12. Fundamentally, revenue grew to $6.84B in 2025 but net losses deepened to $279.4M, with a negative profit margin of -5.17% in 2026. Analyst sentiment remains bullish with a $22.89 consensus target, though recent news highlights margin pressure and execution risks.
The outlook hinges on successful integration of acquisitions and EBITDA growth targets, but high execution risk, negative earnings, and sector headwinds pose substantial downside. With 100% buy ratings from analysts and institutional accumulation, patient investors may see upside if management delivers on its playbook, though volatility is expected near-term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →QXO, Inc. is a distributor of roofing, insulation, waterproofing, and other building materials, serving contractors and builders across US and Canada through its network of branch locations.
Read more on QXO →